New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
AngioDynamics, Inc.
ANGO
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

295M

Medical - Instruments & Supplies

Next Earning date - 03 Jan 2025

295M

Medical - Instruments & Supplies

Next Earning date - 03 Jan 2025

7.27USD
Shape0.73 ( 11.16%)
favorite-chart

Relative Strenght

27
favorite-chart

Volume Buzz

240%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

12%

Quote Panel

Shape
Updated October 22, 2024
1W 17.04 % 1M -2.93 % 3M -2.67 % 1Y 9.80 %

Key Metrics

Shape
  • Market Cap

    295.41M


  • Shares Outstanding

    40.63M


  • Share in Float

    38.64M


  • Dividende

    0


  • Earning Date

    03 Jan 2025


  • Price Target

    7.27


  • Average Volume

    490753


  • Beta

    0.647


  • Range

    5.26-8.25


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.angiodynamics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.91x

P/S Ratio

1.35x

P/B Ratio

0.0

Debt/Equity

-83.0%

Net Margin

$-6.0

EPS

How ANGO compares to sector?

P/E Ratio

Relative Strength

Shape

ANGO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$284M

Shape321%

2025-Revenue

$0.94

Shape-203%

2025-EPS

$7M

Shape180%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Oppenheimer

upgrade

Previous: Not converted

2024-04-05

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+150%

0.01
vs -0.02

Q1.23

arrow
arrow

N/A

-0.03
vs 0.03

Q2.23

arrow
arrow

+100%

0.02
vs 0.01

Q3.23

arrow
arrow

N/A

-0.12
vs -0.06

Q4.23

arrow
arrow

N/A

-0.05
vs 0.01

Q1.24

arrow
arrow

N/A

-0.16
vs -0.03

Q2.24

arrow
arrow

N/A

-0.06
vs 0.02

Q3.24

arrow
arrow

N/A

-0.11
vs -0.12

Q4.24

arrow
arrow

N/A

-0.12
vs -0.05

Q1.25

arrow
arrow

N/A

-0.11
vs -0.16

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+9%

85.4M  vs 78.3M

Q1.23

arrow
arrow

+9%

80.7M  vs 74M

Q2.23

arrow
arrow

+5%

91.1M  vs 87M

Q3.23

arrow
arrow

-4%

78.7M  vs 81.5M

Q4.23

arrow
arrow

-7%

79.1M  vs 85.4M

Q1.24

arrow
arrow

-7%

75.2M  vs 80.7M

Q2.24

arrow
arrow

-22%

71M  vs 91.1M

Q3.24

arrow
arrow

-14%

67.5M  vs 78.7M

Q4.24

arrow
arrow

-10%

70.9M  vs 79.1M

Q1.25

arrow
arrow

-6%

70.6M  vs 75.2M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-2%

-0.02
vs -0.03

Q1.23

arrow
arrow

-2%

-0.02
vs -0.02

Q2.23

arrow
arrow

-6%

-0.06
vs -0.02

Q3.23

arrow
arrow

+11%

0.11
vs -0.06

Q4.23

arrow
arrow

-7%

-0.07
vs 0.11

Q1.24

arrow
arrow

-86%

-0.86
vs -0.07

Q2.24

arrow
arrow

-7%

-0.07
vs -0.86

Q3.24

arrow
arrow

-7%

-0.07
vs -0.07

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

148

148
vs 133

11%

Q4.22

arrow
arrow

149

149
vs 148

1%

Q1.23

arrow
arrow

151

151
vs 149

1%

Q2.23

arrow
arrow

156

156
vs 151

3%

Q3.23

arrow
arrow

151

151
vs 156

-3%

Q4.23

arrow
arrow

149

149
vs 151

-1%

Q1.24

arrow
arrow

133

133
vs 149

-11%

Q2.24

arrow
arrow

134

134
vs 133

1%

Earnings Growth

Latest News